INMB Stock Price | INmune Bio Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch


INmune Bio Inc.

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.

Affiliate Marketing



Source link